Victoza

Victoza (liraglutide) is an injectable medication used to improve blood sugar regulation in individuals with Type 2 diabetes. This medication is non-insulin based and has been shown to lower blood sugar levels within 2 weeks of beginning treatment. In addition, Victoza reduces the risk of stroke, heart attack, and death in adults battling both cardiovascular disease and type 2 diabetes.

Victoza is prescribed for adults and children 10 years of age or older. It is administered once a day via a pen-sized injector. When diabetes is not well controlled by insulin alone, Victoza can be combined with long acting insulin pills, healthy eating, and exercise to effectively keep blood sugar regulated.

Although not a weight loss drug, clinical studies have shown Victoza to promote weight loss for many people. Victoza should not be taken by individuals with endocrine neoplasia type 2 or individuals with a family history of thyroid cancer. In addition, Victoza should not be used by individuals with ketoacidosis or insulin-dependent diabetes.